News from synapse biomedical inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 18, 2013, 14:52 ET
Synapse Biomedical Inc.  (PRNewsFoto/Synapse Biomedical Inc.)

Synapse Biomedical Receives $2.4 Million

Supports Next Generation of NeuRx® Platform  Synapse Biomedical Inc. (www.synapsebiomedical.com) announced today it has been awarded...

Nov 13, 2013, 13:00 ET
Synapse Biomedical.  (PRNewsFoto/Synapse Biomedical Inc.)

Synapse Biomedical Receives Canadian Health Ministry Approval of NeuRx Diaphragm Pacing System (DPS)® For Spinal Cord Injury Breathing Applications

 Synapse Biomedical Inc. (www.synapsebiomedical.com) announced today it has received approval from the Health Canada for its NeuRx DPS®...

Sep 30, 2011, 16:04 ET

Synapse Biomedical obtient l'approbation de la FDA pour le système d'entrainement de diaphragme NeuRx (DPS)® pour traiter la sclérose latérale amyotrophique (SLA)

Synapse Biomedical, Inc. a annoncé que la U.S. Food and Drug Administration (FDA) avait approuvé le Système d'entrainement de...

Sep 30, 2011, 14:44 ET

Synapse Biomedical erhält FDA-Zulassung für das NeuRx Diaphragm Pacing System (DPS)® bei der Behandlung von Amyotropher Lateralsklerose (ALS)

Synapse Biomedical, Inc. gab heute bekannt, die US-Arzneimittelbehörde (FDA) habe das NeuRx Diaphragm Pacing System(DPS)®...

Sep 29, 2011, 14:54 ET

Synapse Biomedical recibe la aprobación de la FDA para el NeuRx Diaphragm Pacing System (DPS)®

- Synapse Biomedical recibe la aprobación de la FDA para el NeuRx Diaphragm Pacing System (DPS)® para tratar la esclerosis lateral...

Sep 29, 2011, 09:56 ET
Synapse Biomedical Receives FDA Humanitarian Use Device Designation for Amyotrophic Lateral Sclerosis (ALS) - synapsebiomedical.com. (PRNewsFoto/Synapse Biomedical Inc.)

Synapse Biomedical Receives FDA Approval for NeuRx Diaphragm Pacing System (DPS)® to Treat Amyotrophic Lateral Sclerosis (ALS)

Synapse Biomedical, Inc. announces that the U.S. Food and Drug Administration (FDA) has approved its NeuRx Diaphragm Pacing System (DPS)® for...

Oct 08, 2010, 11:47 ET
Synapse Biomedical Receives FDA Humanitarian Use Device Designation for Amyotrophic Lateral Sclerosis (ALS) - synapsebiomedical.com. (PRNewsFoto/Synapse Biomedical Inc.)

Synapse Biomedical Receives FDA Humanitarian Use Device Designation for Amyotrophic Lateral Sclerosis (ALS)

Synapse Biomedical Inc. announces today that they have received the U.S. Food and Drug Administration (FDA) designation of the NeuRx Diaphragm...

Jun 18, 2008, 01:00 ET
A F AMERICAN SOCIETY FOR ENGINEERING EDUCATION LOGO AMERICAN SOCIETY FOR ENGINEERING EDUCATION LOGO

American Society for Engineering Education logo. (PRNewsFoto/American Society for Engineering Education)[TK]
 WASHINGTON, DC UNITED STATES
 09/09/2009

Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications

CLEVELAND, June 18 /PRNewswire/ -- Synapse Biomedical Inc. (www.synapsebiomedical.com) announced today it has received approval from the U.S....